CAMBRIDGE COGNITION HOLDINGS PLC Logo

CAMBRIDGE COGNITION HOLDINGS PLC

Develops digital solutions and a platform for CNS clinical trials to assess brain health.

COG | IL

Overview

Corporate Details

ISIN(s):
GB00B8DV9647 (+2 more)
LEI:
213800SZKDIN122EPA96
Country:
United Kingdom
Address:
TUNBRIDGE COURT, TUNBRIDGE LANE, BOTTISHAM, CB25 9TU CAMBRIDGE

Description

Cambridge Cognition Holdings PLC is a neuroscience technology company that develops and markets digital solutions to assess brain health. The company provides an end-to-end platform for Central Nervous System (CNS) clinical trials, featuring a suite of scientifically validated digital cognitive assessments. Its technologies include touchscreen tests, voice analysis, electronic questionnaires, and high-frequency testing, which can be deployed both in-clinic and remotely for decentralized trials. These tools are utilized by pharmaceutical companies, academic research institutions, and healthcare professionals to accelerate drug development and enhance the understanding and treatment of conditions affecting brain health. With over 30 years of scientific validation, its assessments are recognized for their sensitivity in detecting subtle cognitive changes across numerous therapeutic areas.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-05 08:35
Change of Auditor
English 12.6 KB
2025-11-05 08:20
Board Updates
English 19.6 KB
2025-10-01 08:00
Block Listing Return
English 18.0 KB
2025-09-29 08:00
Exercise of Options and Total Voting Rights
English 13.9 KB
2025-09-26 10:59
Holding(s) in Company
English 23.9 KB
2025-09-08 08:00
Holding(s) in Company
English 22.2 KB
2025-09-05 13:04
Holding(s) in Company
English 52.9 KB
2025-09-02 18:21
Holding(s) in Company
English 54.4 KB
2025-08-28 08:01
Changes to Board and Management
English 29.4 KB
2025-08-19 11:10
Monument Therapeutics Partnership with FNIH
English 30.9 KB
2025-08-12 08:00
Launch of Speaker Identification Solution
English 26.7 KB
2025-07-31 08:00
Trading update for period ended 30 June 2025
English 22.4 KB
2025-06-27 13:27
Result of AGM
English 31.6 KB
2025-06-04 08:00
Notice of AGM
English 14.4 KB
2025-05-06 18:59
Holding(s) in Company
English 24.2 KB

Automate Your Workflow. Get a real-time feed of all CAMBRIDGE COGNITION HOLDINGS PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CAMBRIDGE COGNITION HOLDINGS PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CAMBRIDGE COGNITION HOLDINGS PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Avalo Therapeutics, Inc. Logo
Clinical-stage biotech developing treatments for immune-mediated inflammatory diseases.
United States of America
AVTX
Azenta, Inc. Logo
Offers sample management, storage, and multiomics solutions for life sciences.
United States of America
AZTA
BenevolentAI Logo
Applies artificial intelligence to accelerate drug discovery and development.
United Kingdom
BAI
bioAffinity Technologies, Inc. Logo
Develops noninvasive diagnostics and targeted therapeutics for cancer.
United States of America
BIAF
BioArctic Logo
Biopharmaceutical firm developing antibody therapies for neurodegenerative diseases.
Sweden
BIOA
BioInfra Co.,Ltd. Logo
Develops multi-biomarker blood tests for early cancer screening and gene treatments.
South Korea
199730
BioInfra Life Science Inc. Logo
Develops multi-biomarker blood tests for early cancer screening and gene treatments.
South Korea
266470
BioNexus Gene Lab Corp Logo
Develops gene-based diagnostics for early detection of disease susceptibility.
United States of America
BGLC
Biophytis S.A. Logo
Clinical-stage biotech developing therapeutics for age-related degenerative diseases.
France
ALBPS
BioRestorative Therapies, Inc. Logo
Develops adult stem cell therapies for degenerative disc and metabolic disorders.
United States of America
BRTX

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.